These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 8632897

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An anchorage-dependent signal distinct from p42/44 MAP kinase activation is required for cell cycle progression.
    Le Gall M, Grall D, Chambard JC, Pouysségur J, Van Obberghen-Schilling E.
    Oncogene; 1998 Sep 10; 17(10):1271-7. PubMed ID: 9771970
    [Abstract] [Full Text] [Related]

  • 6. Mitogenesis by v-Src: fluctuations throughout G1 of classical immediate early AP-1 and mitogen-activated protein kinase responses that parallel the need for the oncoprotein.
    Wyke AW, Frame MC, Gillespie DA, Chudleigh A, Wyke JA.
    Cell Growth Differ; 1995 Oct 10; 6(10):1225-34. PubMed ID: 8845299
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
    Graham TE, Pfeiffer JR, Lee RJ, Kusewitt DF, Martinez AM, Foutz T, Wilson BS, Oliver JM.
    J Immunol; 1998 Dec 15; 161(12):6733-44. PubMed ID: 9862703
    [Abstract] [Full Text] [Related]

  • 9. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA, Bresler T, Gnainsky J, Smirnoff P, Schwartz B.
    J Endocrinol; 2005 Jun 15; 185(3):577-92. PubMed ID: 15930183
    [Abstract] [Full Text] [Related]

  • 10. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
    Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F.
    EMBO J; 1996 Mar 15; 15(6):1292-300. PubMed ID: 8635462
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rapid activation of mitogen-activated protein kinase and p21ras by prolactin and interleukin 2 in rat Nb2 node lymphoma cells.
    Rao YP, Buckley DJ, Buckley AR.
    Cell Growth Differ; 1995 Oct 15; 6(10):1235-44. PubMed ID: 8845300
    [Abstract] [Full Text] [Related]

  • 15. DDT mimicks estradiol stimulation of breast cancer cells to enter the cell cycle.
    Dees C, Askari M, Foster JS, Ahamed S, Wimalasena J.
    Mol Carcinog; 1997 Feb 15; 18(2):107-14. PubMed ID: 9049186
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
    Greco S, Muscella A, Elia MG, Romano S, Storelli C, Marsigliante S.
    J Cell Physiol; 2004 Oct 15; 201(1):84-96. PubMed ID: 15281091
    [Abstract] [Full Text] [Related]

  • 18. Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth muscle cells through a p27Kip1-independent pathway.
    Fouty BW, Rodman DM.
    Circ Res; 2003 Mar 21; 92(5):501-9. PubMed ID: 12600884
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Basic fibroblast growth factor confers growth inhibition and mitogen-activated protein kinase activation in human breast cancer cells.
    Fenig E, Wieder R, Paglin S, Wang H, Persaud R, Haimovitz-Friedman A, Fuks Z, Yahalom J.
    Clin Cancer Res; 1997 Jan 21; 3(1):135-42. PubMed ID: 9815549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.